Lice Clinics of America (LCA) – the world's largest lice treatment products and services company – recently announced the launch of a unique Title III Equity CF Campaign (Reg CF) in conjunction with StartEngine, allowing the everyday consumer, such as parents, families, healthcare professionals, as well as accredited investors the opportunity to receive equity in a business that will always be in demand: head lice.
LCA created the investment campaign to not only raise capital up to $1 million to advance and expand their ongoing growth strategy – in an industry where failure of the leading global brands has created great opportunity for innovation – but also to let consumers and investors know the brand’s story and mission to put an end to head lice.
No comments:
Post a Comment